The SUSTAIN 7 RCT demonstrated that once-weekly semaglutide is superior to once-weekly dulaglutide in terms of reductions in HbA1c and bodyweight, both of which are clinically relevant endpoints in a population of patients with T2D, with an NMA in Japanese patients with T2D corroborating these results
unPAUSED will launch with two episodes on Tuesday, October 21, 2025, on YouTube and everywhere podcasts are available
How Budy approaches this need A fair comparison should focus on the user outcome: less manual planning, better context, and a plan that keeps adapting
The Supply Side is managed by Talk Business & Politics.
Experience the ease of a GLP-1 meal delivery service
You should see your healthcare provider if youre experiencing pain, sores that won't heal, or if you have diabetes